Table:
begin	end	state
1	11	cytoplasmic
12	31	transmembrane
32	41	non-cytoplasmic
42	74	transmembrane
75	100	cytoplasmic
101	124	transmembrane
125	145	non-cytoplasmic
146	176	transmembrane
177	187	cytoplasmic
188	209	transmembrane
210	228	non-cytoplasmic
229	251	transmembrane
252	271	cytoplasmic
272	292	transmembrane
293	297	non-cytoplasmic
298	317	transmembrane
318	328	cytoplasmic
329	353	transmembrane
354	359	non-cytoplasmic
360	380	transmembrane
381	387	cytoplasmic
388	406	transmembrane
407	409	non-cytoplasmic
410	431	transmembrane
432	450	cytoplasmic
451	470	transmembrane
471	471	non-cytoplasmic

Input:
>WP_068330754.1 NCBI__GCF_001650345.1:WP_068330754.1
MKNLSVSQLIRLFISFGIPLGILLMPIDAIPIDDLTLIQHRLLAIFALAALLWVLEPVPV
FATSILIIALELVMISDKGLHLFRTAPAGHDMGTLIPYTDILGAFSSPIIILFMGGFALA
IAASKYELDNNLARVLLKPFGHQPKFIMLGLMLITAVFSMFMSNTATTVMMLALLAPIVA
SVPKGDIGIKALVLCIPIAANTGGIATPIGTPPNAIALQYLTGEHSISFLGWMMMGLPFV
IVQLAIAWWLLQKMFPSSQQQMKLQLDGTFQKSWQAIVVYITFGLTILLWMTTSLHGMNT
YVVSIIPLAVFTLTGIMGKEELKLINWDVLWLVAGGIAIGLALDKTGLAAALAHAVDYDA
LSPVAVVLTLSILCWLMANFMSNTATANLLMPIAAAVAASMDSLASMGGLQGVLVVVAFS
ASLGMILPVSTPPNSLAYSTGLVESKDMAKTGLIIGLLGLCIVYIGALILT

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server